Main Street Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-60
Closed -$359 876
2026
Q1
$359 Buy
+60
New +$451 ﹤0.01% 801
2025
Q4
Sell
-60
Closed -$641 433
2025
Q3
$641 Hold
60
﹤0.01% 733
2025
Q2
$581 Sell
60
-6
-9% -$62 ﹤0.01% 703
2025
Q1
$974 Buy
66
+6
+10% +$92 ﹤0.01% 703
2024
Q4
$896 Hold
60
﹤0.01% 691
2024
Q3
$1.15K Sell
60
-22
-27% -$456 ﹤0.01% 688
2024
Q2
$1.67K Sell
82
-47
-36% -$934 ﹤0.01% 734
2024
Q1
$2.41K Buy
129
+23
+22% +$395 ﹤0.01% 735
2023
Q4
$1.54K Buy
+106
New +$1.44K ﹤0.01% 1135

Other funds holding OGN

Main Street Group's OGN Position: Q2 2026 in Review

Main Street Group sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 60 shares — an estimated $359 sold.

Main Street Group first reported a position in OGN in Q4 2023 and held it in 9 quarters. The position peaked at $2.41K in Q1 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Main Street Group reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Main Street Group sold 60 Organon & Co shares in Q2 2026, an estimated $359.
  • Main Street Group first reported a position in Organon & Co in Q4 2023 and held it in 9 quarters.
  • Main Street Group's Organon & Co position peaked at $2.41K in Q1 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.